Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method

• US 8,263,328 B2
• Filed: 10/21/2011
• Issued: 09/11/2012
• Est. Priority Date: 10/23/2010
• Status: Active Grant

• Current Assignee: Pop Test LLC
• Original Assignee: Pop Test LLC
• Inventors: Altschul, Randice Lisa, Rapkin, Myron, O'Brien, Rebecca
• Primary Examiner(s): Hanley, Susan
• Assistant Examiner(s): Shen, Bin
• Application Number:
  US13/278,306
• Publication Number:
  US 20120100563A1
• Time in Patent Office: 326 Days
• Field of Search: 435/4, 435/14, 435/25
• US Class Current: 435/4
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: C12Q 1/60 involving cholesterol
• CPC Class Codes: C12Q 1/62 involving uric acid
• CPC Class Codes: G01N 33/523 the element being adapted for a specific analyte
• CPC Class Codes: G01N 33/98 involving alcohol, e.g. ethanol in breath

Abstract

A device is disclosed for conducting a non-invasive analysis of a bodily fluid to determine the presence and level of a certain constituent carried by the bodily fluid. An indicator formulation of the device changes color in response to exposure to the constituent to provide a visible indication of the presence and level of the constituent carried by the bodily fluid. A carrier substrate of the device is constructed of a material having voids providing a high void volume within the substrate. The device is made by applying a chromagen to the carrier substrate to create a chromagen-laden carrier member. Then, a selected reagent having a particular constituent-specific formulation is applied to the chromagen-laden member. The selected reagent then combines with the chromagen, thereby establishing the indicator formulation within the carrier substrate in place for reception of a sample of the bodily fluid.

Claims

1. A method of making a device for conducting a non-invasive analysis of a bodily fluid to determine the presence and the level of a certain constituent carried by the bodily fluid, the device including an indicator formulation capable of changing color in response to exposure to the certain constituent in the presence of ambient air to provide a visible indication of the presence and the level of the certain constituent carried by the bodily fluid, the method comprising:

providing a target area on a carrier substrate of a fibrous material having fibers and voids in a high void volume in juxtaposition with the target area and with fibers within the carrier substrate, with voids establishing communication between fibers and ambient air;

wherein the carrier substrate has a total volume and the high void volume is within a range of about eight to twelve percent of the total volume;

applying a chromagen formulation to fibers of the carrier substrate to create a chromagen-laden carrier member wherein applied chromagen formulation carried on fibers is placed in juxtaposition with voids in the carrier substrate for enabling exposure to ambient air within the voids; and

subsequently applying to the chromagen formulation carried on fibers of the chromagen-laden carrier member a selected reagent having a particular constituent-specific formulation to combine the selected reagent with the chromagen formulation on fibers of the carrier member, thereby establishing the indicator formulation on fibers of the carrier member, in juxtaposition with voids within the carrier substrate and with the target area, in place for communication with ambient air within the voids and reception of a sample of the bodily fluid later placed upon the target area of the carrier substrate and in communication with ambient air within the voids for enabling reaction with the indicator formulation on the fibers, with the sample exposed to ambient air present in the juxtaposed voids as the certain constituent in the sample reacts with the indicator formulation.

2. The method of claim 1 including storing the chromagen-laden carrier member for a subsequent application of the selected reagent at a selected future time, removing from storage the chromagen-laden carrier member at the selected future time, selecting a reagent from reagents having formulations responsive to levels of any one of a plurality of different certain constituents, and then applying the so selected reagent to the removed chromagen-laden carrier member.

3. The method of claim 1 wherein the fibrous material of the carrier substrate comprises a non-woven material.

4. The method of claim 1 wherein the fibrous material of the carrier substrate comprises a non-woven synthetic polymeric material.

5. The method of claim 4 wherein the synthetic polymeric material is a polyester.

6. The method of claim 1 wherein the material of the carrier substrate comprises glass-fiber.

7. The method of claim 1 wherein the chromagen formulation remains the same, while the selected reagent having a constituent-specific formulation is selected from reagents having formulations responsive to levels of any one of a plurality of different certain constituents.

8. The method of claim 7 wherein the certain constituent is any one of glucose, cholesterol, ethanol, uric acid, or galactose.

9. The method of claim 1 wherein the chromagen formulation consists essentially of approximately equal parts of 0.05 to 0.5 M 3-methyl-2-benzothiazolinone hydrazone and 0.05 to 0.5 M dimethylaminobenzoic acid.

10. The method of claim 9 wherein the certain constituent is glucose and the constituent-specific formulation consists essentially of approximately equal amounts of glucose oxidase with an activity of approximately 200 U/mg, and peroxidase with an activity of approximately 200 U/mg in the presence of approximately equal amounts of 0.05 to 0.5 M HEPES, a blend of surface active agents within the range of about 0.1% to 10% each, and a stabilizer.

11. The method of claim 9 wherein the certain constituent is cholesterol and the particular constituent-specific formulation consists essentially of a selected amount of cholesterol esterase with an activity of approximately 180 U/mg, the same selected amount of peroxidase with an activity of approximately 200 U/mg, and twice the selected amount of cholesterol oxidase with an activity of approximately 47 U/mg in the presence of approximately equal amounts of 0.05 to 0.5 M HEPES, a blend of surface active agents within the range of about 0.1% to 10% each, and a stabilizer.

12. The method of claim 9 wherein the certain constituent is ethanol and the particular constituent-specific formulation consists essentially of approximately equal selected amounts of about 1% to 20% PVP K30, about 0.5% to 5.0% ethoxylated surfactant and about 0.05 to 0.5 M phosphate buffer at pH 8.5, one-half the selected amount of alcohol oxidase with an activity of approximately 400 U/ml and one-quarter the selected amount of peroxidase with an activity of approximately 200 U/mg.

13. The method of claim 9 wherein the certain constituent is uric acid and the particular constituent-specific formulation consists essentially of approximately ten parts of uricase, about fifteen parts of ascorbate oxidase and about six parts of peroxidase with an activity of approximately 200 U/mg in 0.05 to 0.5 M phosphate buffered saline at pH 6.4.

14. The method of claim 9 wherein the certain constituent is galactose and the particular constituents-specific formulation consists essentially of approximately five parts of about 0.05 to 0.5 M phosphate buffer at pH 7.0, approximately five parts of peroxidase with an activity of approximately 200 U/mg, and approximately five parts of ethanol, in about twenty-five parts of 10% polyvinyl alcohol, and 4200 units of galactose oxidase.